FDA 21 CFR Part 11: The Complete Guide for Medical Device Companies in 2026
Part 11 governs electronic records and electronic signatures in FDA-regulated industries. This guide explains what it requires, who it applies to, and how to achieve compliance without spending $500K on consultants.
FDA 21 CFR Part 11 is one of the most misunderstood regulations in the life sciences industry. It applies to any FDA-regulated company that uses electronic records or electronic signatures in place of paper records — which in 2026 means virtually every medical device company, pharmaceutical manufacturer, and clinical research organization.
What Part 11 Actually Requires
Part 11 has two core requirements:
1. Electronic Records (Subpart B) - **Audit trails** — Systems must maintain complete, computer-generated audit trails that record who changed what, when, and why - **Access controls** — Limiting system access to authorized individuals through unique user IDs and passwords - **Record integrity** — Electronic records must be protected against unauthorized modification, deletion, or deterioration
2. Electronic Signatures (Subpart C) - Electronic signatures must be equivalent to handwritten signatures - Must include the signer's printed name, date/time, and the meaning of the signature (e.g., "reviewed," "approved") - Biometric and non-biometric signature types are both permitted with different requirements
Computer System Validation (CSV)
This is where most companies struggle. Part 11 requires that computerized systems used to create, modify, or maintain Part 11 records be **validated** — meaning documented evidence that the system consistently produces results that meet its specifications.
The validation lifecycle includes: 1. **User Requirements Specification (URS)** — What the system must do 2. **Functional Specification (FS)** — How the system will meet the URS 3. **Installation Qualification (IQ)** — Verifying the system is installed correctly 4. **Operational Qualification (OQ)** — Verifying the system operates as specified 5. **Performance Qualification (PQ)** — Verifying the system performs as intended under real-world conditions
GAMP 5 and Risk-Based Validation
The GAMP 5 framework (Good Automated Manufacturing Practice) provides the industry standard for risk-based CSV. Systems are categorized by complexity (Category 1-5) with validation scope scaled accordingly. ComplianceGuard's FDA module implements GAMP 5 categorization and generates appropriate IQ/OQ/PQ templates for each category.
What ComplianceGuard Does for Part 11
ComplianceGuard is the only GRC platform with purpose-built FDA 21 CFR Part 11 automation:
- •IQ/OQ/PQ Protocol Generationotocols based on system category and regulatory requirements
- •Validation Master Plan (VMP)A expectations and GAMP 5
- •Audit Trail Monitoringaudit trail completeness and integrity
- •Validation Change Controled systems with impact assessments
Organizations using ComplianceGuard for Part 11 have reduced CSV project timelines from 6 months to 6-8 weeks.
See how Vigil automates this.
Start a free 14-day trial or book a demo to see how PostureIQ, Clio, and ComplianceGuard handle this automatically for your organization.